Issue Date: September 25, 2017
Catalent acquires Cook Pharmica
In a further consolidation of the contract drug-making industry, Catalent is purchasing Cook Pharmica and its 80,000-m2 facility in Bloomington, Ind., for $950 million. Catalent will pay $750 million cash when the deal closes, with the remainder delivered in four annual installments. The acquisition will bolster Catalent’s cell culture manufacturing and also biologics development, manufacturing, and packaging programs.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society